COVID-19 RESOURCES
Peroxigard™, formulated with Accelerated Hydrogen Peroxide®, is approved for use against some of the world’s most dangerous pathogens under the Health Canada emerging viral pathogen guidance, including SARS-CoV-2, the virus that causes COVID-19.
In cases of emerging viral pathogens like SARS-CoV-2, the virus that causes COVID-19, when there is no test that can be conducted to validate the efficacy of a disinfectant, Health Canada utilizes emerging viral pathogen guidance to determine the expected efficacy of a disinfectant against an emerging virus. This guidance, used previously during the 2003 SARS epidemic, mandates that for disinfectant products to be approved, they must be a Health Canada registered Hospital or Broad-Spectrum disinfectant and have proven efficacy against two small, non-enveloped viruses, such as Poliovirus and Parvovirus.
Knowing that emerging viral pathogens are an increasing public health concern, all Peroxigard™ products are designed to meet each of the three levels defined in Health Canada’s emerging viral pathogen guidance. In choosing Peroxigard™ as your daily disinfectant we want to ensure you have the confidence that you are covered in the event of any emerging viral pathogen outbreak.
The Technology That Powers Peroxigard™
We welcome you to take a look at the process behind the technology that powers Peroxigard™. As presented by The Wall Street Journal
Virox Technologies Inc. AHP formula is the cutting edge technology behind Peroxigard™. To get us where we are today, AHP has been trusted and accepted in a multitude of industries, just to name a few; hospitals, cruise ships, animal health and dentistry.